文献速递糖尿病

ACE基因插入/缺失多态性与长期1型糖尿病患者下肢截肢风险的关联

Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

在三个前瞻性1型糖尿病队列共1301名参与者中,基线下肢截肢史在XD基因型(ID或DD)中占7.4%,高于II基因型的4.5%(OR 2.17,95%CI 1.03-4.60)。14年随访期间53人发生下肢截肢,XD携带者风险高于II携带者(HR 3.26,95%CI 1.16-13.67),该关联主要由小截肢驱动而非大截肢。

要点

  • XD基因型(ID或DD)基线下肢截肢史占7.4%,高于II基因型的4.5%(OR 2.17,95%CI 1.03-4.60)。
  • 14年随访中XD携带者发生下肢截肢风险高于II携带者(HR 3.26,95%CI 1.16-13.67)。
  • 该关联由小截肢风险增加驱动,大截肢无此关联。

核心结论

  • ACE D等位基因与1型糖尿病患者下肢截肢风险独立相关,主要为小截肢。

研究设计与样本

  • 三个前瞻性1型糖尿病队列,共1301名参与者(男性54%,年龄41±13岁)。
  • 评估ACE I/D基因型与血浆ACE浓度,下肢截肢定义为小截肢(踝以下、至少一个跖骨列切除)或大截肢(经胫或经股)。
  • 采用线性、逻辑和Cox回归模型评估ACE基因型(XD[ID或DD] vs II)及血浆ACE与现患和 incident 下肢截肢的关联,校正混杂因素。

主要发现

  • 基线下肢截肢史90例(6.9%),XD基因型7.4% vs II基因型4.5%(OR 2.17,95%CI 1.03-4.60)。
  • 14年随访期间53人发生下肢截肢,XD vs II携带者HR 3.26(95%CI 1.16-13.67)。
  • 该关联由小截肢风险增加驱动,大截肢无此关联。
  • 随访结束时D等位基因与现患下肢截肢增加相关(OR 2.48,95%CI 1.33-4.65)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The ACE insertion/deletion (I/D) polymorphism has been widely studied in people with diabetes, albeit not with regard to lower-limb amputation (LLA). We examined associations among this polymorphism, plasma ACE concentration, and LLA in people with type 1 diabetes. RESEARCH DESIGN AND METHODS: ACE I/D genotype and plasma ACE were assessed in three prospective cohorts of participants with type 1 diabetes. LLA was defined as minor (below-the-ankle amputation consisting of at least one ray metatarsal resection) or major (transtibial or transfemoral) amputation. Linear, logistic, and Cox regression models were computed to evaluate the likelihood of prevalent and incident LLA by ACE genotype (XD [ID or ID] vs. II) and plasma ACE, after adjusting for confounders. RESULTS: Among 1,301 participants (male 54%, age 41 ± 13 years), 90 (6.9%) had a baseline history of LLA. Baseline LLA was more prevalent in XD (7.4%) than in II genotype (4.5%, odds ratio [OR] 2.17 [95 %CI 1.03-4.60]). Incident LLA occurred in 53 individuals during the 14-year follow-up and was higher in XD versus II carriers (hazard ratio 3.26 [95% CI 1.16-13.67]). This association was driven by excess risk of minor, but not major, LLA. The D allele was associated with increased prevalent LLA at the end of follow-up (OR 2.48 [1.33-4.65]). LLA was associated with higher mean (95% CI) ACE levels in II (449 [360, 539] vs. 354 [286, 423] ng/mL), but not XD (512 [454, 570] vs. 537 [488, 586]), carriers. CONCLUSIONS: This report is the first of an independent association between ACE D allele and excess LLA risk, mainly minor amputations, in patients with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mohammedi K, Abouleka Y, Carpentier C, et al. Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes. Diabetes Care. 2022. PMID: 34853028. doi:10.2337/dc21-0973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。